Adding oseltamivir to usual primary care reduced recovery time in influenza-like illness

被引：0
|
作者：
Sacks, Henry S. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2020年 / 172卷 / 08期
关键词：
D O I：
10.7326/ACPJ202004210-043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC43 / JC43
页数：1
相关论文
共 50 条
  • [1] Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like Illness
    Bruyndonckx, Robin
    Bilcke, Joke
    van der Velden, Alike W.
    Li, Xiao
    Hens, Niel
    Coenen, Samuel
    Butler, Christopher C.
    Beutels, Philippe
    [J]. VALUE IN HEALTH, 2022, 25 (02) : 178 - 184
  • [2] Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial
    Butler, Christopher C.
    van der Velden, Alike W.
    Bongard, Emily
    Saville, Benjamin R.
    Holmes, Jane
    Coenen, Samuel
    Cook, Johanna
    Francis, Nick A.
    Lewis, Roger J.
    Godycki-Cwirko, Maciek
    Llor, Carl
    Chlabicz, Slawomir
    Lionis, Christos
    Seifert, Bohumil
    Sundvall, Par-Daniel
    Colliers, Annelies
    Aabenhus, Rune
    Bjerrum, Lars
    Harbin, Nicolay Jonassen
    Lindbaek, Morten
    Glinz, Dominik
    Bucher, Heiner C.
    Kovacs, Bernadett
    Jurgute, Ruta Radzeviciene
    Lundgren, Pia Touboul
    Little, Paul
    Murphy, Andrew W.
    De Sutter, An
    Openshaw, Peter
    de Jong, Menno D.
    Connor, Jason T.
    Matheeussen, Veerle
    Ieven, Margareta
    Goossens, Herman
    Verheij, Theo J.
    [J]. LANCET, 2020, 395 (10217): : 42 - 52
  • [3] Neuraminidase inhibitors for influenza-like illness in primary care
    Lee, Nelson
    Ison, Michael
    [J]. LANCET, 2020, 395 (10217): : 4 - 6
  • [4] Consultations for Influenza-Like Illness in Primary Care in The Netherlands: A Regression Approach
    Dolk, F. Christiaan K.
    de Boer, Pieter T.
    Nagy, Lisa
    Donker, Ge A.
    Meijer, Adam
    Postma, Maarten J.
    Pitman, Richard
    [J]. VALUE IN HEALTH, 2021, 24 (01) : 11 - 18
  • [5] Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis
    Harbin, Nicolay Jonassen
    Rystedt, Karin
    Lindbaek, Morten
    Radzeviciene, Ruta
    Westin, Johan
    Gunnarsson, Ronny
    Butler, Christopher C.
    van der Velden, Alike W.
    Verheij, Theo J.
    Sundvall, Par-Daniel
    [J]. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2021, 39 (04) : 527 - 532
  • [6] INFLUENZA-LIKE ILLNESS
    GOLDWATER, S
    [J]. BRITISH MEDICAL JOURNAL, 1960, 1 (MAR26): : 962 - 963
  • [7] Influenza-like illness
    Barroyer, Pierre
    [J]. ACTUALITES PHARMACEUTIQUES, 2022, 61 (621): : 26 - 27
  • [8] Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir
    Nordstrom, BL
    Sung, L
    Suter, P
    Szneke, P
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (05) : 761 - 768
  • [9] Oseltamivir Treatment for Children with Influenza-Like Illness in China: A Cost-Effectiveness Analysis
    Shen, Kunling
    Xiong, Tengbin
    Tan, Seng Chuen
    Wu, Jiuhong
    [J]. PLOS ONE, 2016, 11 (04):
  • [10] Defining influenza-like illness
    Rashid, Harunor
    Rafiq, Shafquat M.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (11): : 1285 - 1286
12345